These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5974574)

  • 1. [Examination of healthy relatives of the patients with Duchenne's progressive muscular dystrophy].
    Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Emeryk B; Wasowicz B; Slucka C; Hetnarska L; Bendarzewska B; Pucek Z
    Neurol Neurochir Psychiatr Pol; 1966 Nov; 16(11):1225-34. PubMed ID: 5974574
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation on healthy individuals from families of patients with Duchenne type muscular dystrophy.
    Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Emeryk B; Wasowicz B; Slucka C; Hetnarska L; Bendarzewska B; Pucek Z
    Pol Med J; 1968; 7(1):228-37. PubMed ID: 5652928
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies in progressive muscular dystrophy.
    Prot J
    Pol Med J; 1972; 11(4):1004-12. PubMed ID: 5078704
    [No Abstract]   [Full Text] [Related]  

  • 4. Duchenne's muscular dystrophy: the electrocardiogram in female relatives.
    Mann O; DeLeon AC; Perloff JK; Simanis J; Horrigan FD
    Am J Med Sci; 1968 Jun; 255():376-81. PubMed ID: 5654956
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 6. [Description of a family with Duchenne's type of progressive muscular dystrophy with an unusually benign course].
    Domzal T; Kotowicz J
    Neurol Neurochir Pol; 1967; 1(5):593-8. PubMed ID: 6064457
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
    Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
    Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
    [No Abstract]   [Full Text] [Related]  

  • 9. [On Becker's benign muscular dystrophy: study of a family with 10 affected members in 6 generations].
    Caruso G; Campanella G
    Acta Neurol (Napoli); 1968; 23(4):709-31. PubMed ID: 5747395
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-statistical considerations on a group of 22 patients with progressive muscular dystrophy].
    Garofalo E; Marcer V
    Fracastoro; 1966; 59(6):621-38. PubMed ID: 5998705
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurogenic muscular atrophies of childhood. Case records of the Clinica Pediatrica "G. Gaslini" of Genoa from 1959 to 1967].
    Berio A; Fregonese B; Macagno F
    Minerva Pediatr; 1968 Feb; 20(8):397-415. PubMed ID: 5745074
    [No Abstract]   [Full Text] [Related]  

  • 12. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The heart in muscular diseases. 1. Muscular dystrophy, especially Duchenne's muscular dystrophy].
    Beckmann R; Schmit B
    Med Klin; 1976 Jul; 71(27):1135-45. PubMed ID: 781499
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical and histopathological studies of the carrier state in Duchenne's muscular dystrophy.
    Ionasescu V; Vuia O; Luca N; Popa P
    Confin Neurol; 1968; 30(5):289-300. PubMed ID: 4891427
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies in progressive muscular dystrophy].
    Prot J
    Neurol Neurochir Pol; 1971; 5(4):473-8. PubMed ID: 5122052
    [No Abstract]   [Full Text] [Related]  

  • 16. Short PR interval and abnormal systolic time interval as a method of carrier detection in maternal relations of patients with muscular dystrophy.
    Pazare AR; Patil SM; Tankhiwale SR
    J Assoc Physicians India; 1992 Feb; 40(2):82-3. PubMed ID: 1629140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muscular dystrophy and its problems].
    Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K
    Nihon Rinsho; 1968 Sep; 26(9):2184-98. PubMed ID: 5752294
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlations between aldolasaemia and motor unit territory in the evaluation of Duchenne's progressive muscular dystrophy.
    Radu H; Migea S; Bordeianu L; Radu A; Ciunganu B
    Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):415-6. PubMed ID: 4176628
    [No Abstract]   [Full Text] [Related]  

  • 19. [Duchenne's form of progressive muscular dystrophy according to data of the neurologic department of the Academy of Medicine in Warsaw].
    Chelmicka-Kizlich E; Fidziańska A; Jedrzejowska H
    Neurol Neurochir Psychiatr Pol; 1966 Nov; 16(11):1243-50. PubMed ID: 5974575
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipid peroxidation in children with Duchenne's hereditary myopathy].
    Grinio LP; Orlov ON; Prilipko LL; Kagan VE
    Biull Eksp Biol Med; 1984 Oct; 98(10):423-5. PubMed ID: 6498321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.